Literature DB >> 11918126

Chronic kidney disease: stating the managed care case for early treatment. Discussion and consensus of presentations of economic analyses, managed care organization case studies, and opportunities for intervention in a managed care setting. May 3-5, 2001 Chicago, Illinois.

.   

Abstract

Based on an analysis of data from the National Health and Nutrition Examination Survey, approximately 20 million people currently have some degree of decreased glomerular filtration rate or overt kidney disease. Despite numerous challenges to be overcome, managed care organizations and the nephrology community are seeking ways to collaborate in improving the quality of care of such patients. Using current data, as well as information about the cost of care, priority is being given to the establishment of early intervention programs to maximize the existing healthcare infrastructure and to improve the clinical outcomes of chronic kidney disease and end-stage renal disease.

Entities:  

Mesh:

Year:  2002        PMID: 11918126

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  1 in total

1.  Health plan retention and pharmacy costs of newly diagnosed patients with chronic kidney disease in a managed care population.

Authors:  Maureen Kubacki; Chureen Carter; Alan D L Herrera; Jim Wang; Janice M Lopez; Catherine T Piech
Journal:  Am Health Drug Benefits       Date:  2009-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.